874492-01-0

Usage

Uses

Used in Organic Synthesis:
2-(4-CHLOROPHENYL)-5-NITROPYRIDINE is used as a building block in organic synthesis for the creation of more complex molecules. Its unique structure, featuring a chlorophenyl and nitro group, allows for various chemical reactions and modifications, contributing to the synthesis of a wide range of organic compounds.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-(4-CHLOROPHENYL)-5-NITROPYRIDINE is used as a starting material for the development of new drugs. Its chemical properties and structural features make it a promising candidate for the design and synthesis of novel therapeutic agents with potential applications in various medical fields.
Used in Materials Science:
2-(4-CHLOROPHENYL)-5-NITROPYRIDINE also finds potential applications in materials science. Its unique chemical structure and properties can be utilized in the development of new materials with specific characteristics, such as improved stability, reactivity, or other desirable properties for various applications.

Upstream product

• 4487-59-6 2-bromo-5-nitropyridine 
• 1679-18-1 4-Chlorophenylboronic acid 
• 4548-45-2 2-chloro-5-nitropyridine 
• 5575-51-9 tris(4-chlorophenyl)bismuthane 

Downstream Products

• 1477524-64-3 diethyl 4'-(5-nitropyridin-2-yl)-5,6-dihydro-[1,1'-biphenyl]-4,4(3H)-dicarboxylate 
• 1477524-65-4 (1-(4-(5-aminopyridin-2-yl)phenyl)-6-bromo-2-oxabicyclo[2.2.2]octan-4-yl)methanol 
• 1477524-66-5 (1-(4-(5-aminopyridin-2-yl)phenyl)-2-oxabicyclo[2.2.2]octan-4-yl)methanol 
• 1477524-63-2 5-nitro-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine 
• 1477524-01-8 2-(1-(4-(5-((5-cyclobutyl-1,3,4-oxadiazol-2-yl)amino)pyridin-2-yl)phenyl)-2-oxabicyclo[2.2.2]octan-4-yl)acetic acid 
• 1477524-68-7 1-(4-(5-((5-cyclobutyl-1,3,4-oxadiazol-2-yl)amino)pyridin-2-yl)phenyl)-2-oxabicyclo[2.2.2]octane-4-carbaldehyde 

Relevant academic research and scientific papers

Cross-coupling study of iodo/chloropyridines and 2-chloroquinoline with atom-economic triarylbismuth reagents under Pd-catalysis

This study describes the palladium-catalyzed couplings of iodopyridines, chloropyridines, and chloroquinoline with atom-economic BiAr3 reagents in sub-stoichiometric loadings. Mono-arylations of iodo and chloropyridines produced arylpyridines i

NAPHTHALENE DERIVATIVE

The present invention provides compounds which can regulate VCP activity. The present invention provides the compound of formula (I) (R is as defined in the description) or oxides, esters, prodrugs, pharmaceutically acceptable salts or solvates thereof. The compounds can regulate VCP activity, and thus are useful for treating VCP-mediated diseases such as neurodegenerative diseases.

AGENT FOR TREATMENT OF EYE DISEASES

The present invention provides agents effective to treat eye diseases, pharmaceutical compositions comprising them, methods for preparing pharmaceuticals for treatment of eye diseases comprising using the agents, use of the agents in manufacture of pharma

CYCLIC BRIDGEHEAD ETHER DGAT1 INHIBITORS

The invention relates to compounds of formula (I): useful for treating disorders mediated by acyl coA-diacylglycerol acyl transferase 1 (DGAT1), e.g. metabolic disorders. The invention also provides methods of treating such disorders, and compounds and compositions etc. for their treatment.